Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.
Current yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerg...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3796569?pdf=render |
id |
doaj-f6e91471e32d431baab54f6c858f932d |
---|---|
record_format |
Article |
spelling |
doaj-f6e91471e32d431baab54f6c858f932d2020-11-25T02:23:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7716410.1371/journal.pone.0077164Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.Douglas V DolfiKathleen D MansfieldRaj K KurupatiSenthil KannanSusan A DoyleHildegund C J ErtlKenneth E SchmaderE John WherryCurrent yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerging pandemic influenza virus strains to include in the vaccines. Thus, there has been considerable emphasis on understanding broadly protective immunological mechanisms for influenza virus. Recent studies have implicated memory CD4 T cells in heterotypic immunity in animal models and in human challenge studies. Here we examined how influenza virus vaccination boosted CD4 T cell responses in younger versus aged humans. Our results demonstrate that while the magnitude of the vaccine-induced CD4 T cell response and number of subjects responding on day 7 did not differ between younger and aged subjects, fewer aged subjects had peak responses on day 14. While CD4 T cell responses were inefficiently boosted against NA, both HA and especially nucleocaspid protein- and matrix-(NP+M) specific responses were robustly boosted. Pre-existing CD4 T cell responses were associated with more robust responses to influenza virus NP+M, but not H1 or H3. Finally pre-existing strain-specific NAb decreased the boosting of CD4 T cell responses. Thus, accumulation of pre-existing influenza virus-specific immunity in the form of NAb and cross-reactive T cells to conserved virus proteins (e.g. NP and M) over a lifetime of exposure to infection and vaccination may influence vaccine-induced CD4 T cell responses in the aged.http://europepmc.org/articles/PMC3796569?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Douglas V Dolfi Kathleen D Mansfield Raj K Kurupati Senthil Kannan Susan A Doyle Hildegund C J Ertl Kenneth E Schmader E John Wherry |
spellingShingle |
Douglas V Dolfi Kathleen D Mansfield Raj K Kurupati Senthil Kannan Susan A Doyle Hildegund C J Ertl Kenneth E Schmader E John Wherry Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. PLoS ONE |
author_facet |
Douglas V Dolfi Kathleen D Mansfield Raj K Kurupati Senthil Kannan Susan A Doyle Hildegund C J Ertl Kenneth E Schmader E John Wherry |
author_sort |
Douglas V Dolfi |
title |
Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. |
title_short |
Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. |
title_full |
Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. |
title_fullStr |
Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. |
title_full_unstemmed |
Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. |
title_sort |
vaccine-induced boosting of influenza virus-specific cd4 t cells in younger and aged humans. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
Current yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerging pandemic influenza virus strains to include in the vaccines. Thus, there has been considerable emphasis on understanding broadly protective immunological mechanisms for influenza virus. Recent studies have implicated memory CD4 T cells in heterotypic immunity in animal models and in human challenge studies. Here we examined how influenza virus vaccination boosted CD4 T cell responses in younger versus aged humans. Our results demonstrate that while the magnitude of the vaccine-induced CD4 T cell response and number of subjects responding on day 7 did not differ between younger and aged subjects, fewer aged subjects had peak responses on day 14. While CD4 T cell responses were inefficiently boosted against NA, both HA and especially nucleocaspid protein- and matrix-(NP+M) specific responses were robustly boosted. Pre-existing CD4 T cell responses were associated with more robust responses to influenza virus NP+M, but not H1 or H3. Finally pre-existing strain-specific NAb decreased the boosting of CD4 T cell responses. Thus, accumulation of pre-existing influenza virus-specific immunity in the form of NAb and cross-reactive T cells to conserved virus proteins (e.g. NP and M) over a lifetime of exposure to infection and vaccination may influence vaccine-induced CD4 T cell responses in the aged. |
url |
http://europepmc.org/articles/PMC3796569?pdf=render |
work_keys_str_mv |
AT douglasvdolfi vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT kathleendmansfield vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT rajkkurupati vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT senthilkannan vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT susanadoyle vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT hildegundcjertl vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT kennetheschmader vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans AT ejohnwherry vaccineinducedboostingofinfluenzavirusspecificcd4tcellsinyoungerandagedhumans |
_version_ |
1724858436632444928 |